19-53810312-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_144687.4(NLRP12):​c.1347C>G​(p.Ala449Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00456 in 1,613,762 control chromosomes in the GnomAD database, including 175 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.020 ( 84 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 91 hom. )

Consequence

NLRP12
NM_144687.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.778

Publications

1 publications found
Variant links:
Genes affected
NLRP12 (HGNC:22938): (NLR family pyrin domain containing 12) This gene encodes a member of the CATERPILLER family of cytoplasmic proteins. The encoded protein, which contains an N-terminal pyrin domain, a NACHT domain, a NACHT-associated domain, and a C-terminus leucine-rich repeat region, functions as an attenuating factor of inflammation by suppressing inflammatory responses in activated monocytes. Mutations in this gene cause familial cold autoinflammatory syndrome type 2. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]
NLRP12 Gene-Disease associations (from GenCC):
  • familial cold autoinflammatory syndrome 2
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-53810312-G-C is Benign according to our data. Variant chr19-53810312-G-C is described in ClinVar as Benign. ClinVar VariationId is 330032.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.778 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0617 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NLRP12NM_144687.4 linkc.1347C>G p.Ala449Ala synonymous_variant Exon 3 of 10 ENST00000324134.11 NP_653288.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NLRP12ENST00000324134.11 linkc.1347C>G p.Ala449Ala synonymous_variant Exon 3 of 10 1 NM_144687.4 ENSP00000319377.6
NLRP12ENST00000345770.9 linkc.1347C>G p.Ala449Ala synonymous_variant Exon 3 of 9 1 ENSP00000341428.5
NLRP12ENST00000391772.1 linkc.1347C>G p.Ala449Ala synonymous_variant Exon 3 of 7 1 ENSP00000375652.1

Frequencies

GnomAD3 genomes
AF:
0.0199
AC:
3024
AN:
152096
Hom.:
84
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0637
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0110
Gnomad ASJ
AF:
0.0346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.000809
Gnomad OTH
AF:
0.0167
GnomAD2 exomes
AF:
0.00669
AC:
1675
AN:
250556
AF XY:
0.00524
show subpopulations
Gnomad AFR exome
AF:
0.0668
Gnomad AMR exome
AF:
0.00408
Gnomad ASJ exome
AF:
0.0333
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000768
Gnomad OTH exome
AF:
0.00523
GnomAD4 exome
AF:
0.00297
AC:
4335
AN:
1461548
Hom.:
91
Cov.:
40
AF XY:
0.00277
AC XY:
2014
AN XY:
727074
show subpopulations
African (AFR)
AF:
0.0651
AC:
2180
AN:
33480
American (AMR)
AF:
0.00508
AC:
227
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0324
AC:
847
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000139
AC:
12
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53082
Middle Eastern (MID)
AF:
0.00607
AC:
35
AN:
5768
European-Non Finnish (NFE)
AF:
0.000531
AC:
590
AN:
1112008
Other (OTH)
AF:
0.00735
AC:
444
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
313
626
940
1253
1566
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0199
AC:
3030
AN:
152214
Hom.:
84
Cov.:
32
AF XY:
0.0190
AC XY:
1417
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.0637
AC:
2646
AN:
41540
American (AMR)
AF:
0.0109
AC:
167
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.0346
AC:
120
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.000809
AC:
55
AN:
68016
Other (OTH)
AF:
0.0165
AC:
35
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
136
272
408
544
680
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00962
Hom.:
10
Bravo
AF:
0.0236
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.00109
EpiControl
AF:
0.00101

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial cold autoinflammatory syndrome 2 Benign:3
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 08, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

May 06, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autoinflammatory syndrome Benign:1
Feb 17, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.63
DANN
Benign
0.39
PhyloP100
-0.78
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111234757; hg19: chr19-54313566; API